IGLON5 and Chorea: Besides sleep disorders, gait problems, bulbar dysfunction and movement disorders, with chorea being reported in about a third of patients, dysautonomia, neurocognitive deficits and behavioral symptoms represent other common features in anti‐IgLON5 disease.4, 5